Filing Details
- Accession Number:
- 0000014272-14-000248
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-17 17:16:54
- Reporting Period:
- 2014-10-15
- Filing Date:
- 2014-10-17
- Accepted Time:
- 2014-10-17 17:16:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1198959 | M James Cornelius | Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.10 Par Value | Disposition | 2014-10-15 | 100,000 | $48.92 | 169,041 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- On July 31, 2014, the reporting person agreed to contribute Bristol-Myers Squibb Company common stock to an exchange fund in exchange for shares of the exchange fund. The exchange fund closed on October 15, 2014 and the shares were contributed on that date. The Bristol-Myers Squibb Company common stock was valued at $48.92 per share for the purpose of determining the number of shares of the exchange fund issuable to the reporting person.